Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 3/2004

01-09-2004 | Original article

An assessment of the feasibility of sentinel lymph node-guided surgery for gastric cancer

Authors: Hiroshi Isozaki, Toshikazu Kimura, Noriaki Tanaka, Katuaki Satoh, Sasau Matsumoto, Motoki Ninomiya, Toshihide Ohsaki, Masanobu Mori, the Esophagus Gastrointestinal (EGI) Surgical Treatment Study Group* 

Published in: Gastric Cancer | Issue 3/2004

Login to get access
Metadata
Title
An assessment of the feasibility of sentinel lymph node-guided surgery for gastric cancer
Authors
Hiroshi Isozaki
Toshikazu Kimura
Noriaki Tanaka
Katuaki Satoh
Sasau Matsumoto
Motoki Ninomiya
Toshihide Ohsaki
Masanobu Mori
the Esophagus Gastrointestinal (EGI) Surgical Treatment Study Group* 
Publication date
01-09-2004
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue 3/2004
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-004-0283-6

Other articles of this Issue 3/2004

Gastric Cancer 3/2004 Go to the issue

Editorial

Sentinel node mapping for gastric cancer: is the jury still out?

Original article

Pathologic characteristics of gastric cancer in the elderly: a retrospective study of 994 surgical patients

Editorial

Submitting an article on gastric cancer: to which journal?

Review article

TNM and Japanese staging systems for gastric cancer: how do they coexist?

Case report

Route from the paraaortic lymphatic system to the tracheobronchial lymph nodes evidenced on lymphangiogram in a patient with gastric cancer

Original article

Regulation of drug sensitivity of gastric cancer cells by human calcyclin-binding protein (CacyBP)
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits